Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Otovowen is a homeopathic and plant-based combination medication traditionally used for the treatment of acute otitis media (AOM) and symptoms of upper respiratory tract infections, particularly in children. It is formulated as an oral solution containing a mixture of tinctures and potencies derived from several medicinal plants and minerals, including *Echinacea*, *Aconitum napellus*, *Capsicum annuum*, and *Chamomilla recutita*. The product is designed to provide anti-inflammatory and immunostimulatory effects, aiming to resolve ear inflammation and reduce the necessity for conventional antibiotic or analgesic therapy in uncomplicated cases. It is developed and manufactured by the German pharmaceutical company Weber & Weber.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Otovowen.